GlucoTrack (GCTK) News Today $10.59 +5.72 (+117.45%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$8.79 -1.80 (-17.00%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GCTK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period GlucoTrack Secures $3.6M Convertible Promissory NoteSeptember 12 at 5:51 PM | tipranks.comGlucoTrack Secures $20 Million Investment AgreementSeptember 11 at 5:31 PM | tipranks.comGlucotrack to Participate in the Q3 Virtual Investor SummitSeptember 11 at 8:00 AM | globenewswire.comGlucoTrack, Inc.: Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate HighlightsAugust 15, 2025 | finanznachrichten.deGlucoTrack Reports Q2 Results and Corporate HighlightsAugust 15, 2025 | msn.comGlucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate HighlightsAugust 14, 2025 | globenewswire.comGlucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, CardiologyAugust 6, 2025 | globenewswire.comGlucoTrack to Showcase CBGM at Diabetes MeetingAugust 1, 2025 | msn.comGlucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual MeetingJuly 31, 2025 | globenewswire.comGlucoTrack, Sarepta, TNF Pharma Dominate Weekly Retail Health Care Buzz — Here’s WhyJuly 21, 2025 | msn.comGlucotrack, Inc. Successfully Repurchases Over 90% of Series A Warrants as Part of Capital Formation Strategy - NasdaqJuly 10, 2025 | nasdaq.comGlucotrack Announces Repurchase of Series A WarrantsJuly 8, 2025 | globenewswire.comGlucotrack reports positive results from first human trial of blood glucose monitor - Investing.comJune 26, 2025 | investing.comGlucotrack's Investigational Cont. Glucose Monitor Shows Accuracy In First-In-Human Study - NasdaqJune 26, 2025 | nasdaq.comGlucoTrack Inc trading resumesJune 25, 2025 | msn.comWhy Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?June 25, 2025 | benzinga.comGlucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific SessionsJune 25, 2025 | globenewswire.comGlucoTrack, Inc.: Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing RequirementsJune 13, 2025 | finanznachrichten.deGlucotrack announces 1-for-60 reverse stock split effective June 16June 13, 2025 | investing.comGlucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing RequirementsJune 12, 2025 | globenewswire.comGlucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific SessionsJune 4, 2025 | globenewswire.comGlucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhDMay 28, 2025 | globenewswire.comGCTK stock plunges to 52-week low, touches $0.13May 23, 2025 | uk.investing.comGlucotrack Establishes Patient Advisory Board to Inform Diabetes Technology DevelopmentMay 20, 2025 | globenewswire.comGlucoTrack, Inc.: Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 15, 2025 | finanznachrichten.deGlucotrack Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 14, 2025 | globenewswire.comGlucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose MonitorMay 13, 2025 | globenewswire.comGlucoTrack to participate in FORGETDIABETES initiativeApril 17, 2025 | markets.businessinsider.comGlucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic PancreasApril 16, 2025 | globenewswire.comGlucoTrack, OneTwo Analytics collaborate to study analysis on CBG MonitorApril 5, 2025 | markets.businessinsider.comGlucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose MonitorApril 3, 2025 | globenewswire.comGlucotrack Reports Full Year 2024 Financial Results and Recent Corporate HighlightsMarch 31, 2025 | globenewswire.comGlucoTrack to present first-in-human study for CBGM at 2025 conference on ATTDMarch 21, 2025 | markets.businessinsider.comImplantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes CareMarch 19, 2025 | theglobeandmail.comGlucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for DiabetesMarch 19, 2025 | globenewswire.comGlucotrack finalizes equity securities salesMarch 15, 2025 | investing.comGlucotrack appoints Umpierrez to Medical Advisory BoardFebruary 26, 2025 | markets.businessinsider.comGlucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board MemberFebruary 26, 2025 | globenewswire.comEQS-News: Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical TrialFebruary 25, 2025 | markets.businessinsider.comGlucoTrack prices offering of 2.6M shares of common stock at $1.15February 5, 2025 | markets.businessinsider.comGlucotrack sets terms for $3 million public stock offeringFebruary 5, 2025 | msn.comGlucotrack soars on completion of first human clinical study of continuous blood glucose monitorFebruary 5, 2025 | msn.comGlucotrack, Inc. Announces Pricing of $3.0 Million Public OfferingFebruary 4, 2025 | globenewswire.comGlucoTrack announces completion of first in human clinical study of CGMFebruary 4, 2025 | markets.businessinsider.comGlucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose MonitorFebruary 4, 2025 | globenewswire.comGlucoTrack Inc trading halted, news pendingFebruary 3, 2025 | markets.businessinsider.comGCTK Stock Plummets to 52-Week Low of $0.06 Amid Market TurbulenceJanuary 30, 2025 | msn.comGlucotrack Strengthens Leadership Team with Appointment of New Chief Financial OfficerJanuary 29, 2025 | globenewswire.comGlucotrack Announces ISO 13485:2016 CertificationJanuary 21, 2025 | globenewswire.comGlucoTrack (NASDAQ: IGAP)January 16, 2025 | fool.com Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GCTK Media Mentions By Week GCTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GCTK News Sentiment▼0.480.92▲Average Medical News Sentiment GCTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GCTK Articles This Week▼81▲GCTK Articles Average Week Get the Latest News and Ratings for GCTK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for GlucoTrack and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies INBS News IINN News BTCY News STSS News MHUA News CODX News DHAI News XAIR News FEMY News LYRA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GCTK) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GCTK Stock Alerts